Characteristic | Number of cases (%) |
---|---|
Patient number | 270 |
Age (Years) | |
Mean | 58.8 |
Range | 32–86 |
Postmenopausal (%) | 66.3 % |
Mean tumor size (mm) | 22.73 |
VLD patients | 21.47 (6–60) |
MID patients | 23.46 (3–90) |
Mean BMI | 26.70 |
VLD patients | 25.46 (20.24–46.87) |
MID patients | 28.84 (17.96–41.53) |
HER2 positive | 133 (49.3 %) |
Triple Negative | 17 |
Tumor Pathological T classification | |
T1 | 152 (56.3 %) |
T2 | 95 (35.2 %) |
T3 | 10 (3.7 %) |
T4 | 13 (4.8 %) |
Tumor N classification | |
N0 | 100 (37.0 %) |
N1 | 117 (43.3 %) |
N2 | 34 (12.6 %) |
N3 | 19 (7.0 %) |
Definitive histology | |
Ductal | 223 (82.6) |
Lobular | 26 (9.6 %) |
Mucinous | 4 (1.5 %) |
Other | 17 (6.3 %) |
Histological grade | |
1 | 22 (8.1 %) |
2 | 120 (44.4 %) |
3 | 128 (47.4 %) |
Follow up time / years | |
Mean | 8.03 |
Range | 0.39–13.22 |